Furthermore, serum C-reactive protein was significantly increased in the active disease group (46.4 ± 35.6 mg/l) when compared to IBD patients in remission (21.6 ± 14.3 mg/l; p = 0.006). This evidence concerns the gene CRP and inflammatory bowel disease.